|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park JM, Ryu WS, Kim JH, Park SS, Kim SJ,
Kim CS and Mok YJ: Prognostic factors for advanced gastric cancer:
Stage-stratified analysis of patients who underwent curative
resection. Cancer Res Treat. 38:13–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Canyilmaz E, Soydemir G, Serdar L, Uslu
GH, Sahbaz A, Colak F, Kandaz M, Bahat Z and Yoney A: Evaluation of
prognostic factors and survival results in gastric carcinoma:
Single center experience from Northeast Turkey. Int J Clin Exp Med.
7:2656–2666. 2014.PubMed/NCBI
|
|
5
|
Hundahl SA, Phillips JL and Menck HR: The
National Cancer Data Base Report on poor survival of U.S. gastric
carcinoma patients treated with gastrectomy: Fifth Edition American
Joint Committee on Cancer staging, proximal disease, and the
‘different disease’ hypothesis. Cancer. 88:921–932. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh
KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al: Screening
for gastric cancer in Asia: Current evidence and practice. Lancet
Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hamashima C, Shibuya D, Yamazaki H, Inoue
K, Fukao A, Saito H and Sobue T: The Japanese guidelines for
gastric cancer screening. Jpn J Clin Oncol. 38:259–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tashiro A, Sano M, Kinameri K, Fujita K
and Takeuchi Y: Comparing mass screening techniques for gastric
cancer in Japan. World J Gastroenterol. 12:4873–4874.
2006.PubMed/NCBI
|
|
9
|
Leja M, You W, Camargo MC and Saito H:
Implementation of gastric cancer screening-the global experience.
Best Pract Res Clin Gastroenterol. 28:1093–1106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park JY, Karsa L and Herrero R: Prevention
strategies for gastric cancer: A global perspective. Clin Endosc.
47:478–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liew CC: Method for the detection of gene
transcripts in blood and uses there of U.S. Patent Application No.
2002000268730. 1999.
|
|
12
|
Liew CC, Ma J, Tang HC, Zheng R and
Dempsey AA: Peripheral blood transcriptome dynamically reflects
system wide biology: A potential diagnostic tool. J Lab Clin Med.
147:126–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burczynski ME: Transcriptional profiling
of peripheral blood in oncologySurrogate tissue analysis: Genomic,
proteomic and metabolomic approaches. Burczynski ME and Rockett JC:
(edition). Taylor and Francis; Boca Raton: pp. 47–63. 2006
|
|
14
|
Liew CC and Dzau VJ: Molecular genetics
and genomics of heart failure. Nat Rev Genet. 5:811–825. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ponnampalam SN, Kamaluddin NR, Zakaria Z,
Matheneswaran V, Ganesan D, Haspani MS, Ryten M and Hardy JA: A
blood-based gene expression and signaling pathway analysis to
differentiate between high and low grade gliomas. Oncol Rep.
37:10–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vanburen P, Ma J, Chao S, Mueller E,
Schneider DJ and Liew CC: Blood gene expression signatures
associate with heart failure outcomes. Physiol Genomics.
43:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marshall KW, Mohr S, Khettabi FE, Nossova
N, Chao S, Bao W, Ma J, Li XJ and Liew CC: Blood-based biomarker
panel for stratifying current risk for colorectal cancer. Int J
Cancer. 126:1177–1186. 2010.PubMed/NCBI
|
|
18
|
Osman I, Bajorin DF, Sun TT, Zhong H,
Douglas D, Scattergood J, Zheng R, Han M, Marshall KW and Liew CC:
Novel blood biomarkers of human urinary bladder cancer. Clin Cancer
Res. 12:3374–3380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liong ML, Lim CR, Yang H, Chao S, Bong CW,
Leong WS, Das PK, Loh CS, Lau BE, Yu CG, et al: Blood-based
biomarkers of aggressive prostate cancer. PLoS One. 7:e458022012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Twine NC, Stover JA, Marshall B, Dukart G,
Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, et
al: Disease-associated expression profiles in peripheral blood
mononuclear cells from patients with advanced renal cell carcinoma.
Cancer Res. 63:6069–6075. 2003.PubMed/NCBI
|
|
21
|
Baine MJ, Chakraborty S, Smith LM, Mallya
K, Sasson AR, Brand RE and Batra SK: Transcriptional profiling of
peripheral blood mononuclear cells in pancreatic cancer patients
identifies novel genes with potential diagnostic utility. PLoS One.
6:e170142011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burakoff R, Chao S, Perencevich M, Ying J,
Friedman S, Makrauer F, Odze R, Khurana H and Liew CC: Blood-based
biomarkers can differentiate ulcerative colitis from Crohn's
disease and noninflammatory diarrhea. Inflamm Bowel Dis.
17:1719–1725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burakoff R, Hande S, Ma J, Banks PA,
Friedman S, Makrauer F and Liew CC: Differential regulation of
peripheral leukocyte genes in patients with active Crohn's disease
and Crohn's disease in remission. J Clin Gastroenterol. 44:120–126.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuang MT, Nossova N, Yager T, Tsuang MM,
Guo SC, Shyu KG, Glatt SJ and Liew CC: Assessing the validity of
blood-based gene expression profiles for the classification of
schizophrenia and bipolar disorder: A preliminary report. Am J Med
Genet B Neuropsychiatr Genet. 133B:1–5. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Glatt SJ, Everall IP, Kremen WS, Corbeil
J, Sásik R, Khanlou N, Han M, Liew CC and Tsuang MT: Comparative
gene expression analysis of blood and brain provides concurrent
validation of SELENBP1 up-regulation in schizophrenia. Proc Natl
Acad Sci USA. 102:15533–15538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Glatt SJ, Stone WS, Nossova N, Liew CC,
Seidman LJ and Tsuang MT: Similarities and differences in
peripheral blood gene-expression signatures of individuals with
schizophrenia and their first-degree biological relatives. Am J Med
Genet B Neuropsychiatr Genet. 156B:869–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speedet TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
MAQC Consortium, . Shi L, Reid LH, Jones
WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville
F, Kawasaki ES, et al: The MicroArray quality control (MAQC)
project shows inter- and intraplatform reproducibility of gene
expression measurements. Nat Biotechnol. 24:1151–1161. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han M, Liew CT, Zhang HW, Chao S, Zheng R,
Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, et al: Novel, blood-based
five-gene panel biomarker set for the detection of colorectal
cancer. Clin Cancer Res. 14:455–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Burakoff R, Pabby V, Onyewadume L, Odze R,
Adackapara C, Wang W, Friedman S, Hamilton M, Korzenik J, Levine J,
et al: Blood-based biomarkers used to predict disease activity in
Crohn's disease and ulcerative colitis. Inflamm Bowel. Dis.
21:1132–1140. 2015.
|
|
31
|
Chao S, Cheng C and Liew CC: Mining the
dynamic genome: A method for identifying multiple disease
signatures using quantitative RNA expression analysis of a single
blood sample. Microarrays (Bassel). 4:671–689. 2015. View Article : Google Scholar
|
|
32
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: A nonparametric approach.
Biometrics. 44:837–845. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Z, Dou M, Yao X, Tang H, Li Z and
Zhao X: Potential biomarkers in diagnosis of human gastric cancer.
Cancer Invest. 34:115–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kalnina Z, Meistere I, Kikuste I, Tolmanis
I, Zayakin P and Line A: Emerging blood-based biomarkers for
detection of gastric cancer. World J Gastroenterol. 21:11636–11653.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsumura N, Zembutsu H, Yamaguchi K,
Sasaki K, Tsuruma T, Nishidate T, Denno R and Hirata K:
Identification of novel molecular markers for detection of gastric
cancer cells in the peripheral blood circulation using genome-wide
microarray analysis. Exp Ther Med. 2:705–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sakai Y, Honda M, Fujinaga H, Tatsumi I,
Mizukoshi E, Nakamoto Y and Kaneko K: Common transcriptional
signature of tumor-infiltrating mononuclear inflammatory cells and
peripheral blood mononuclear cells in hepatocellular carcinoma
patients. Cancer Res. 68:10267–10279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tu H, Sun H, Lin Y, Ding J, Nan K, Li Z,
Shen Q and Wei Y: Oxidative stress upregulates PDCD4 expression in
patients with gastric cancer via miR-21. Curr Pharm Des.
20:1917–1923. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma G, Zhang H, Dog M, Zheng X, Ozaki I,
Matsuhashi S and Guo K: Downregulation of programmed cell death 4
(PDCD4) in tumorigenesis and progression of human digestive tract
cancers. Tumour Biol. 34:3879–3885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu H, Zeng J, Liang X, Wang W, Zhou Y, Sun
Y, Liu S, Li W, Chen C and Jia J: Helicobacter pylori promotes
epithelial-mesenchymal transition in gastric cancer by
downregulating programmed cell death protein 4 (PDCD4). PLoS One.
9:e1053062014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Narayan G, Bourdon V, Chaganti S,
Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider
A, Pothuri B, et al: Gene dosage alterations revealed by cDNA
microarray analysis in cervical cancer: Identification of candidate
amplified and overexpressed genes. Genes Chromosomes Cancer.
46:373–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jeong MS, Hwang EY, Kim HT, Yoo M and Jang
SB: Purification of caudal-related homeodomain transcription factor
and its binding characterization. J Microbiol Biotechnol.
19:1557–1564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Janicke B, Hegardt C, Krogh M, Onning G,
Akesson B, Cirenajwis HM and Oredsson SM: The antiproliferative
effect of dietary fiber phenolic compounds ferulic acid and
p-coumaric acid on the cell cycle of Caco-2 cells. Nutr Cancer.
63:611–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cotterchio M, Lowcock E, Bider-Canfield Z,
Lemire M, Greenwood C, Gallinger S, Gallinger S and Hudson T:
Association between variants in atopy-related immunologic candidate
genes and pancreatic cancer risk. PLoS One. 10:e01252732015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nookala RK, Langemeyer L, Pacitto A,
Ochoa-Montaño B, Donaldson JC, Blaszczyk BK, Chirgadze DY, Barr FA,
Bazan JF and Blundell TL: Crystal structure of folliculin reveals a
hidDENN function in genetically inherited renal cancer. Open Biol.
2:1200712012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lezon-Geyda K, Najfeld V and Johnson EM:
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic
syndrome and progression to acute myelogenous leukemia. Leukemia.
15:954–962. 2001. View Article : Google Scholar : PubMed/NCBI
|
